Circulating Exosomal MicroRNAs as Potential Biomarkers for Pulmonary Embolism
Clinical and Applied Thrombosis/Hemostasis
Published online on March 03, 2026
Abstract
Clinical and Applied Thrombosis/Hemostasis, Volume 32, January-December 2026.
Pulmonary embolism (PE) is difficult to diagnose due to nonspecific symptomatology and lack of accurate diagnostic tools. PE can be categorized into low-risk, submassive, and massive based on severity. Changes in several plasma and serum microRNAs (miRNA) ...
Pulmonary embolism (PE) is difficult to diagnose due to nonspecific symptomatology and lack of accurate diagnostic tools. PE can be categorized into low-risk, submassive, and massive based on severity. Changes in several plasma and serum microRNAs (miRNA) ...